Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses
US7141241B2 · kind B2 · utility
7Cited by
88References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 8, 2002 |
| Grant date | Nov 28, 2006 |
| Priority date | — |
| Expiry date | Feb 8, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an oral delivery system containing a bacteriophage associated lysin enzyme for the treatment of [Streptococcus pneumoniae and] Hemophilus influenzae sinus/nasal infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.